Starting HPV vaccination earlier for better protection
The HPV9-10 Trial: Early Initiation of HPV Vaccination
This study is looking at whether starting the HPV vaccine for kids at ages 9-10, instead of the usual 11-12, helps more children finish the vaccine series, which is important for preventing HPV-related diseases like cervical cancer, and it aims to make parents feel more comfortable about getting their kids vaccinated early.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado Denver NIH-funded |
| Lab location | 1 site (Aurora, UNITED STATES) |
| Project ID | NIH-10846731 on NIH RePORTER |
What this research studies
This research investigates the benefits of initiating the HPV vaccination at ages 9-10 instead of the commonly recommended age of 11-12. The study aims to determine if earlier vaccination leads to higher completion rates of the vaccine series, which is crucial for effective prevention of HPV-related diseases, including cervical cancer. By focusing on cancer prevention rather than sexual activity, the research seeks to address parental concerns and improve vaccine acceptance among adolescents. The methodology includes analyzing vaccination rates and parental attitudes towards early vaccination.
Who could benefit from this research
Good fit: Ideal candidates for this research are children aged 9-10 years who are eligible for the HPV vaccination.
Not a fit: Patients who are older than 10 years or those who have already completed the HPV vaccination series may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly increase HPV vaccination rates among young adolescents, leading to better protection against HPV-related cancers.
How similar studies have performed: Previous studies have shown that earlier initiation of the HPV vaccine can lead to higher completion rates, suggesting that this approach may be effective.
Where this research is happening
Aurora, UNITED STATES
- University of Colorado Denver — Aurora, United States (Active)
Researchers
- Principal investigator: Kempe, Allison — University of Colorado Denver
- Study coordinator: Kempe, Allison
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.